The results of Iranian patients with gastric cancer confirmed the findings of other countries about the overexpression of OLFM4 in gastric cancer tumors, which indicates that this gene can serve as a potential biological marker for prediction, diagnosis, and treatment of GC. This evidence concerns the gene OLFM4 and gastric cancer.